Pharmacokinetic and pharmacodynamic study of interaction of rhodiola rosea SHR-5 extract with warfarin and theophylline in rats

Phytotherapy Research

Volumn 23, Issue 3, 2009, Pages 351-357

  Panossian, Alexander ^a   Hovhannisyan, Areg ^b   Abrahamyan, Hasmik ^b   Gabrielyan, Emil ^b   Wikman, Georg ^a  

^a Swedish Herbal Institute   (Sweden)

^b Armenian Ministry of Health   (Armenia)

Author keywords

Drug drug interaction; Pharmacokinetic; Rhodiola rosea; Theophylline; Warfarin

Indexed keywords

AMINOPHYLLINE; HYPERICUM PERFORATUM EXTRACT; JARSIN 300; RHODIOLA ROSEA EXTRACT; SHR 5; THEOPHYLLINE; UNCLASSIFIED DRUG; WARFARIN;

ANIMAL EXPERIMENT; ANTICOAGULATION; ARTICLE; CONTROLLED STUDY; DEPRESSION; DRUG INDICATION; MALE; NONHUMAN; PHARMACODYNAMICS; RAT;

ANIMALS; ANTICOAGULANTS; HERB-DRUG INTERACTIONS; MALE; PLANT EXTRACTS; PLANTS, MEDICINAL; RATS; RATS, WISTAR; RHODIOLA; THEOPHYLLINE; WARFARIN;

RATTUS; RHODIOLA ROSEA;

EID: 61549117804     PISSN: 0951418X     EISSN: 10991573     Source Type: Journal    
DOI: 10.1002/ptr.2631     Document Type: Article

References (38)

1. Aksenova RA, Zotova MI, Nekhoda MF, Cherdantsev SG. 1968. Comparative characteristics of the stimulants and adaptogenic effects of Rhodiola rosea preparations. In Stimulants of the Central Nervous System, vol. 2, Saratikov AS (ed.). Tomsk University Press: Tomsk, 3-12.
2. Basely RC. 1978. Disposition of Toxic Drugs and Chemicals in Man. Biomed Publishers: Canton, 78-81.
3. Darbinyan V, Kteyan A, Panossian A, Gabielian E, Wikman G, Wagner H. 2000. Rhodiola rosea in stress induced fatigue - a double-blind cross-over study of a standardized extract HR-5 with a repeated low-dose regimen on the mental performance of healthy physicians during night duty. Phytomedicine 7: 365-371.
4. Darbinyan V, Aslanyan G, Amroyan E, Gabrielyan E, Malmström C, Panossian A. 2007. Clinical trial of Rhodiola rosea L. extract SHR-5 in the treatment of mild to moderate depression. Nordic J Psychiatry 61: 343-348.
5. EEC Directive 75/318. 1994. Pharmacokinetics and Metabolic Studies in the Safety Evaluation of New Medicinal Products in Animals. EU GMP Supplemental Quality Guidelines (available at http://pharmacos.eudra.org/F2/ eudralex/vol-3/pdfs-en/3bs11aen.pdf).
6. Estonian Ministry of Health Affairs. 1998. Regulation No. 7, Annex 1, 21 January. Government of Estonia: Tallin.
7. Etheridge AS, Black SR, Patel PR, So J, Mathews JM. 2007. An in vitro evaluation of cytochrome P450 inhibition and P-glycoprotein interaction with goldenseal, Ginkgo biloba, grape seed, milk thistle, and ginseng extracts and their constituents. Planta Med 73: 731-741.
8. Foster BC, Vandenhoek S, Hanna J, Akhtar MH, Krantis A. 1999. Effect of natural health products on cytochrome P-450 drug metabolism. Can J Infect Dis 10B: 150.
9. Henderson L, Yue QY, Bergquist C, Gerden B, Arlett P. 2002. St John's wort (Hypericum perforatum): drug interactions and clinical outcomes. Br J Clin Pharmacol 54: 349-356.
10. Hewick DS, McEwen J. 1973. Plasma half-life, plasma metabolites and anticoagulant efficacies of the enantiomers of warfarin in man. J Pharm Pharmacol 25: 458-465.
11. Iwata H, Tezuka Y, Kadota S, Hiratsuka A, Watabe T. 2004. Identification and characterization of potent CYP3A4 inhibitors in Schisandra fruit extract. Drug Metab Dispos 32: 1351-1358.
12. Izzo AA, Ernst E. 2001. Interactions between herbal medicines and prescribed drugs: a systematic review. Drugs 61: 2163-2175.
13. Janetzky K, Marreale AP. 1997. Probable interaction between warfarin and Ginseng. Am J Health System Pharm 54: 692-693.
14. Kaminsky LS, Zhang ZY. 1997. Human P450 metabolism of warfarin. Pharmacol Ther 73: 67-74.
15. Linné C. 1749. Materia Medica. Liber I. de Plantis: Stockholm, 168.
16. Makino T, Mizuno F, Mizukami H. 2006. Does a kampo medicine containing Schisandra fruit affect pharmacokinetics of nifedipine like grapefruit juice? Biol Pharm Bull 29: 2065-2069.
17. Markowitz JS, Donovan JL, DeVane CL et al. 2003. Effect of St John's Wort on drug metabolism by induction of cytochrome P450 3A4 enzyme. J Am Med Assoc 290: 1500-1504.
18. Mashkovskij MD. 1977. Medicines (Manual of Pharmacotherapy for Doctors), Part I, 8th edn. Meditsina: Moscow, 133.
19. Müller-Dietz H. 1969. Arzneipflanzen in der Sowietunion. Ber Osteuropa-Instituts an der Freien Univ Berlin 44: 91-93.
20. Muravijeva DA. 1978. Pharmacognosy (with Fundamentals of Biochemistry of Medicinal Herbs). Meditsina: Moscow, 541-546.
21. National Pharmacopoeia Committee. 1996. Pharmacopoeia article PA 42-2163-96, Extractum Rhodiolae fluidum. The Russian Federation Ministry of Health and Medical Industry: Moscow.
22. National Pharmacopoeia of the USSR. 1990. 11th edn - Pharmacopoeia paper 75, Rhizome and roots of Rhodiola rosea, The USSR Ministry of Health, Moscow. Meditsina 2: 317-319; update No 2 dated 19-05-1999.
23. Niopas I, Toon S, Aarons L, Rowland M. 1999. The effect of cimetidine on the steady-state pharmacokinetics and pharmacodynamics of warfarin in humans. Eur J Clin Pharmacol 55: 399-404.
24. Olsson EMG, von Schéele B, Panossian AG. In press. A randomized double-blind placebo controlled parallel group study of SHR-5 extract of Rhodiola rosea roots as treatment for patients with stress related fatigue.
25. Panosyan A, Wagner H. 2005. Stimulating effects of adaptogens: an overview of clinical trials of adaptogens with particular reference on their efficacy at single dose administration. Phytother Res 19: 819-838.
26. Pharmacopée Française. 1976. 9th edn - Premiere Partie Monographs, La Commission Nationale de Pharmacopee: Paris, II-214, 100-101.
27. Ramzan IM, Levy G. 1986. Kinetic of drug action in disease States XVI. Pharmacodynamics of Theophylline-induced seizures in rats. J Pharmacol and Exper Therap 236: 708-713.
28. Ritschel WA. 1999. Handbook of Basic Pharmacokinetics. Drug Intelligence Publication: Hamilton, 503.
29. Saratikov AS, Krasnov EA. 2004. Rhodiola rosea (Golden root). Tomsk University Publishing House: Tomsk, 292.
30. Saratikov AS, Krasnov EE, Chnikina LA et al. 1968. Rhodiolosid ein neues Glykosid aus Rhodiola rosea und seine pharmakologischen Eigenschaften. Pharmazie 23: 392-395.
31. Shevtsov VA, Zholus BI, Shervaly VI et al. 2003. A randomised trial of two different doses of a SHR-5 Rhodiola rosea extract versus placebo and control of capacity for mental work. Phytomedicine 10: 95-105.
32. Smolinske SC. 1999. Dietary supplement-drug interactions. J Am Med Women's Assoc 54: 191-192, 195.
33. Sokolov SY, Ivashin VK, Zapesochnaya GG, Kurkin VA, Shchavlinskii AN. 1985. Studies of neurotropic activity of new compounds isolated from Rhodiola rosea L. Chem Pharm J (Moscow) 19: 1367-1371.
34. Sparschuch H. 1775. Pharmacopoae Svecia. Holmia, 39.
35. Spasov AA, Wikman GK, Mandrikov VB, Mironova IA, Neumoin VV. 2000. A double-blind, placebo-controlled pilot study of the stimulating and adaptogenic effect of Rhodiola rosea SHR-5 extract on the fatigue of students caused by stress during an examination period with a repeated low-dose regimen. Phytomedicine 7: 85-89.
36. Turova AD, Sapozhnikova EN. 1984. Medicinal Plants of the USSR and their Use, 4th edn. Meditsina: Moscow, 35-37.
37. Zapadnyuk IN, Zapadnyuk KI, Zapadnyuk LP, Zapadnyuk KM. 1983. Laboratory Animals. Visha Schkola: Kiev, 383.
38. Zhu M, Chan KW, Ng LS, Chang Q, Chang S, Li R. 1999. Possible influences of Ginseng on the pharmacokinetics and pharmacodynamics of warfarin in rats. J Pharm Pharmacol 51:175-180.